Jonathan W Friedberg. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Antibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, Murine-DerivedAntineoplastic Agents/therapeutic useClinical Trials as TopicHumansLymphoma, B-Cell/drug therapyLymphoma, B-Cell/pathologyLymphoma, Large B-Cell, Diffuse/drug therapyLymphoma, Large B-Cell, Diffuse/pathologyRisk FactorsRituximab
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, Murine-DerivedAntineoplastic AgentsRituximab
Year: 2006 PMID: 16648037 DOI: 10.1016/S1470-2045(06)70668-4
Source DB: PubMed Journal: Lancet Oncol ISSN: 1470-2045 Impact factor: 41.316